Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial (Q37240299)

From Wikidata

Jump to navigation Jump to search

scientific article published on 02 September 2013

Language	Label	Description	Also known as
English	Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial	scientific article published on 02 September 2013

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial (English)

1 reference

Europe PubMed Central

19 August 2017

0 references

0 references

hospitalization

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Aldo P. Maggioni

object named as

Aldo P Maggioni

1

0 references

Gregg C. Fonarow

object named as

Gregg C Fonarow

3

0 references

Mihai Gheorghiade

12

object named as

Mihai Gheorghiade

1 reference

Europe PubMed Central

19 August 2017

5

object named as

Faiez Zannad

1 reference

Europe PubMed Central

19 August 2017

Stephen J Greene

2

object named as

Stephen J Greene

1 reference

Europe PubMed Central

19 August 2017

Fabio Baschiera

8

object named as

Fabio Baschiera

1 reference

Europe PubMed Central

19 August 2017

Claudio R Gimpelewicz

10

object named as

Claudio R Gimpelewicz

1 reference

Europe PubMed Central

19 August 2017

7

object named as

Eldrin F Lewis

1 reference

Europe PubMed Central

19 August 2017

ASTRONAUT Investigators and Coordinators

13

object named as

ASTRONAUT Investigators and Coordinators

1 reference

Europe PubMed Central

19 August 2017

9

object named as

Tsushung A Hua

1 reference

Europe PubMed Central

19 August 2017

Anastasia Lesogor

11

object named as

Anastasia Lesogor

1 reference

Europe PubMed Central

19 August 2017

author name string

Michael Böhm

4

1 reference

Europe PubMed Central

19 August 2017

Scott D Solomon

6

1 reference

Europe PubMed Central

19 August 2017

publication date

2 September 2013

1 reference

Europe PubMed Central

19 August 2017

European Heart Journal

1 reference

Europe PubMed Central

19 August 2017

34

1 reference

Europe PubMed Central

19 August 2017

3117-3127

1 reference

Europe PubMed Central

19 August 2017

40

1 reference

Europe PubMed Central

19 August 2017

Heart failure–associated hospitalizations in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800848

6 September 2017

Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800848

6 September 2017

Cardiorenal end points in a trial of aliskiren for type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800848

6 September 2017

Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800848

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800848

6 September 2017

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800848

6 September 2017

National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800848

6 September 2017

Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800848

6 September 2017

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800848

6 September 2017

The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800848

6 September 2017

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800848

6 September 2017

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800848

6 September 2017

Serum aldosterone is associated with mortality and re-hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: analysis from the EVEREST trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800848

3 September 2018

Rehospitalization for heart failure: problems and perspectives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800848

3 September 2018

Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800848

3 September 2018

Eplerenone in patients with systolic heart failure and mild symptoms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800848

3 September 2018

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800848

3 September 2018

Statistics in medicine--reporting of subgroup analyses in clinical trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800848

3 September 2018

Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3800848

3 September 2018

Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT342

21 January 2018

Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT342

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHT342

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37240299&oldid=2114298630"